Literature DB >> 13662574

Absorption, metabolism and elimination of pempidine in the rat.

D F MUGGLETON, H W READING.   

Abstract

Pempidine (1,2,2,6,6-pentamethylpiperidine) is a ganglion blocking agent introduced recently for the treatment of hypertension by oral administration of its hydrogen tartrate. It can be estimated colorimetrically by coupling with methyl orange, or fluorimetrically by reaction with eosin in xylene, the limits of sensitivity being 0.5 mug./ml. and 0.001 mug./ml. respectively. These methods, combined with appropriate extraction techniques, were suitable for estimating pempidine in aqueous solutions of its salts, in biological fluids and the like, and for investigating the biochemical properties of the drug when given orally to rats in amounts similar to those used clinically.When administered orally to rats pempidine was rapidly absorbed, the maximum concentration in plasma being attained after 30 min. The drug was preferentially taken up by erythrocytes and a red cell/plasma partition ratio of about 1.2 established with clinical doses. Pempidine was soon distributed throughout the body, including the cerebrospinal fluid, and the highest concentrations were found in kidney, spleen and liver. Pempidine also entered the foetus and passed thence into the amniotic fluid. Protein-binding of the drug occurred only to a very limited extent and there was little evidence that it was metabolized. Pempidine was excreted rapidly in urine during 24 hr. following oral administration.

Entities:  

Keywords:  PIPERIDINES/metabolism

Mesh:

Substances:

Year:  1959        PMID: 13662574      PMCID: PMC1481796          DOI: 10.1111/j.1476-5381.1959.tb01384.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  6 in total

1.  Excretion of mecamylamine after intravenous and oral administration.

Authors:  K D ALLANBY; J R TROUNCE
Journal:  Br Med J       Date:  1957-11-23

2.  Some physico-chemical factors in drug action.

Authors:  B B BRODIE; C A HOGBEN
Journal:  J Pharm Pharmacol       Date:  1957-06       Impact factor: 3.765

3.  1:2:2:6:6-Pentamethylpiperidine: a new hypotensive drug.

Authors:  G E LEE; W R WRAGG; S J CORNE; N D EDGE; H W READING
Journal:  Nature       Date:  1958-06-21       Impact factor: 49.962

4.  Pharmacology and clinical use of pempidine in the treatment of hypertension.

Authors:  M HARINGTON; P KINCAID-SMITH; M D MILNE
Journal:  Lancet       Date:  1958-07-05       Impact factor: 79.321

5.  Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine).

Authors:  J E BAER; K H BEYER; S F PAULSON; H F RUSSO
Journal:  Am J Physiol       Date:  1956-07

6.  Pharmacological properties of pempidine (1:2:2:6:6-pentamethylpiperidine), a new ganglion-blocking compound.

Authors:  S J CORNE; N D EDGE
Journal:  Br J Pharmacol Chemother       Date:  1958-09
  6 in total
  2 in total

1.  Plasma pempidine concentrations in hypertensives.

Authors:  C T DOLLERY; D EMSLIE-SMITH; D F MUGGLETON
Journal:  Br Med J       Date:  1960-02-20

2.  ACTIONS OF MECAMYLAMINE, DIMECAMINE, PEMPIDINE AND THEIR TWO QUATERNARY METHO-SALTS AT THE NEUROMUSCULAR JUNCTION.

Authors:  J G BLACKMAN; C RAY
Journal:  Br J Pharmacol Chemother       Date:  1964-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.